Therapeutic Drugs

Showing 185–192 of 203 resultsSorted by latest

Anti-Idiopathic Pulmonary Fibrosis Drugs Market Report 2021-2031
Full Details This product has multiple variants. The options may be chosen on the product page
Top 25 Vaccines Market Forecast to 2029
Full Details This product has multiple variants. The options may be chosen on the product page
Next-Generation Biologics Market Forecast to 2029
Full Details This product has multiple variants. The options may be chosen on the product page
Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029
Full Details This product has multiple variants. The options may be chosen on the product page
Global Acute Myeloid Leukaemia Market Forecast to 2029
Full Details This product has multiple variants. The options may be chosen on the product page
Attention Deficit Hyperactivity Disorder Drugs Market Forecast to 2029
Full Details This product has multiple variants. The options may be chosen on the product page
Asia Vaccines Market Forecast to 2029
Full Details This product has multiple variants. The options may be chosen on the product page
Global Drug Discovery Outsourcing Market Forecast to 2028
Full Details This product has multiple variants. The options may be chosen on the product page

Need custom work?

Do you have custom requirements that we can help you with?

Any specific country, geo-regional, niche segmentation, or competitive intelligence?

Email us today to discuss your needs: contactus@visiongain.com

Methodology

Our reports are built on a rigorous methodology that combines in-depth primary research with critical analysis of verified data sources. Visiongain’s approach is human-led, expert-informed, and precision-driven.

What Sets Us Apart:

Cross-Referenced Data Validation
Data points are checked against multiple trusted sources to ensure accuracy, consistency, and transparency.

Primary Interviews
Direct conversations with industry leaders, product managers, engineers, and senior executives ensure first-hand insights.

Verified Financials & Filings
We analyse annual reports, SEC filings, and audited financial data to cross-validate market performance and projections.

Project Pipeline & Technology Analysis
Detailed reviews and analysis of tech innovations, development pipelines, projects and patents across all sectors.

Regulatory and Market Mapping
We monitor policy shifts, global trade dynamics, and regulatory updates influencing market behaviour, including live tariff tracking and scenario modelling.

Reports catalogue

Would you like to get the latest Visiongain reports catalogue?

What are the dynamic growth sectors? Where are the regional business opportunities?

Which technologies will prevail, and which are the leading companies succeeding in these sectors, and why?

Discover Visiongain’s full range of business intelligence reports for definitive answers to business-critical questions.

If so contact us today; +44 207 336 6100 or email; contactus@visiongain.com

Industry Market Reports

Message us today

Therapeutic Drugs

Anti-Idiopathic Pulmonary Fibrosis Drugs Market Report 2021-2031

Top 25 Vaccines Market Forecast to 2029

Next-Generation Biologics Market Forecast to 2029

Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029

Global Acute Myeloid Leukaemia Market Forecast to 2029

Attention Deficit Hyperactivity Disorder Drugs Market Forecast to 2029

Asia Vaccines Market Forecast to 2029

Global Drug Discovery Outsourcing Market Forecast to 2028

Need custom work?

Methodology

What Sets Us Apart:

Reports catalogue

Distributed Fibre Optic Sensing Goes Strategic

Ophthalmic Drugs Market

Ammonia Market

Global Defence: Industrial Policy & Procurement Realignment

Fill-Finish Manufacturing Is Now a Strategic Constraint

Sustainable Bioplastics Market to Grow at 11.8% CAGR as Procurement Shifts to Volume Contracts

Longevity Market to Grow at 8.6% CAGR as Institutional Adoption Accelerates

Alzheimer’s Therapeutics Market to Grow at 18.2% CAGR as Access Frameworks Evolve

Clients & Partners

Your cart (items: 0)